Location History:
- West Orange, NJ (US) (1997 - 2008)
- Cambridge, NJ (US) (2010)
Company Filing History:
Years Active: 1997-2010
Title: Innovations by Lata Ramanathan: Pioneering Research in Aurora Kinase
Introduction
Lata Ramanathan, a leading inventor based in West Orange, NJ, has made significant contributions to the field of biochemistry through her innovative research. With an impressive portfolio that includes five patents, Ramanathan has focused her efforts on understanding and manipulating proteins within cellular processes, particularly in relation to the Aurora 2 kinase.
Latest Patents
Ramanathan's latest inventions, notably in the area of crystallizing the Aurora 2 kinase catalytic domain, represent cutting-edge advancements in molecular biology. Her patents detail nucleic acids encoding an active human Aurora 2 kinase catalytic domain and methods of growing X-ray diffractable crystals of these polypeptides. The patents also describe a new crystalline form of the catalytic domain, which has broad applications in structure-assisted drug design aimed at identifying compounds capable of modulating the enzymatic activity of the Aurora 2 kinase.
Career Highlights
Lata Ramanathan is currently affiliated with Schering Corporation, where she applies her expertise to drive innovation in pharmaceutical development. Her work has not only contributed to her personal accolades but has also advanced the field of therapeutic drug discovery, particularly in cancer research, where controlling kinase activity is crucial.
Collaborations
Ramanathan collaborates with esteemed colleagues, including Thierry Olivier Fischmann and Vincent Stewart Madison. These partnerships highlight the collaborative nature of scientific research, allowing for the exchange of ideas and expertise that propel innovation forward.
Conclusion
In summary, Lata Ramanathan's contributions to the field of biochemistry through her innovative inventions and collaborative efforts establish her as a notable inventor. Her work on Aurora 2 kinase not only enhances our understanding of this critical protein but also opens new avenues for therapeutic interventions. As innovation continues to evolve, Ramanathan's research will undoubtedly play a pivotal role in advancing biomedical science.